Immorta Bio Publishes Over 70% Increased Longevity in Aging Animals by its Patented Therapeutic Combination

Peer-Reviewed Study Demonstrates the Essential Role of Senolytic Immunotherapy in Unleashing Anti-Aging Potential of Stem Cells MIAMI and SAN DIEGO, June 11, 2026 /PRNewswire/ -- Immorta Bio, a scientific longevity biotechnology company focused on Treating Diseases of Aging and Treating...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.